These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8196079)

  • 21. Screening Mammography Use Among Older Women Before and After the 2009 U.S. Preventive Services Task Force Recommendations.
    Chang CH; Bynum JP; Onega T; Colla CH; Lurie JD; Tosteson AN
    J Womens Health (Larchmt); 2016 Oct; 25(10):1030-1037. PubMed ID: 27427790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NIH/NCI Consensus Development Meeting on breast cancer screening. Response of the National Cancer Institute.
    Yale J Biol Med; 1978; 51(1):9-11. PubMed ID: 676352
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for breast cancer.
    Fletcher SW; Black W; Harris R; Rimer BK; Shapiro S
    J Natl Cancer Inst; 1994 Apr; 86(7):558-61. PubMed ID: 8133541
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening women aged 40-49 years: where are we today?
    Smith RA
    J Natl Cancer Inst; 1995 Aug; 87(16):1198-200. PubMed ID: 7563159
    [No Abstract]   [Full Text] [Related]  

  • 25. Procedures to be followed for expedited review of single patient protocols -- recommendations of the RAC, March 2, 1993.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 1993 Jun; 4(3):307. PubMed ID: 11643143
    [No Abstract]   [Full Text] [Related]  

  • 26. Mammography to molecular biology: opportunities and obstacles in developing early breast cancer detection methods.
    Nass SJ
    Oncol Nurs Forum; 2002; 29(1):21-2. PubMed ID: 11817488
    [No Abstract]   [Full Text] [Related]  

  • 27. Breast care imaging: ghost of past?
    Emahiser LJ; Wood BD
    Radiol Technol; 2012; 83(4):397-400. PubMed ID: 22461349
    [No Abstract]   [Full Text] [Related]  

  • 28. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.
    Wernli KJ; Arao RF; Hubbard RA; Sprague BL; Alford-Teaster J; Haas JS; Henderson L; Hill D; Lee CI; Tosteson ANA; Onega T
    J Womens Health (Larchmt); 2017 Aug; 26(8):820-827. PubMed ID: 28177856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The breast cancer screening controversy and the National Institutes of Health Consensus Development Conference on Breast Cancer Screening for Women Ages 40-49.
    Kopans DB
    Radiology; 1999 Jan; 210(1):4-9. PubMed ID: 9885578
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant DNA Advisory Committee: minutes of meeting, 3 Oct 1988.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Recomb DNA Tech Bull; 1988 Dec; 11(4):155-94. PubMed ID: 11644344
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant DNA Advisory Committee: minutes of meeting, 10-11 Feb 1992.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 1992 Oct; 3(5):563-91. PubMed ID: 11643034
    [No Abstract]   [Full Text] [Related]  

  • 32. When Guidelines Conflict: A Case Study of Mammography Screening Initiation in the 1990s.
    Jacobson M; Kadiyala S
    Womens Health Issues; 2017; 27(6):692-699. PubMed ID: 28935360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer screening: a 35-year perspective.
    Fletcher SW
    Epidemiol Rev; 2011; 33():165-75. PubMed ID: 21697257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral consequences of conflict-oriented health news coverage: the 2009 mammography guideline controversy and online information seeking.
    Weeks BE; Friedenberg LM; Southwell BG; Slater JS
    Health Commun; 2012; 27(2):158-66. PubMed ID: 21823950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Breast Cancer Screening: Impact of U.S. Preventive Services Task Force Recommendations.
    Dehkordy SF; Hall KS; Roach AL; Rothman ED; Dalton VK; Carlos RC
    Am J Prev Med; 2015 Sep; 49(3):419-22. PubMed ID: 25841980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protect NIH's DNA advisory committee.
    Adelman ZN; Albritton LM; Boris-Lawrie K; Buchmeier MJ; Cannon P; Cho M; DiGiusto D; Donahue JK; Federoff HJ; Hammarskjold ML; Hardison AD; Hearing P; Lee B; Lee DA; Porteus MH; Ross LF; Ross SR; Wooley DP; Zoloth L
    Science; 2018 Oct; 362(6413):409-410. PubMed ID: 30361364
    [No Abstract]   [Full Text] [Related]  

  • 37. Remarks for the RAC Committee meeting of January 14, 1993, regarding compassionate use exemption.
    Healy B
    Hum Gene Ther; 1993 Apr; 4(2):195-7. PubMed ID: 8494929
    [No Abstract]   [Full Text] [Related]  

  • 38. Obstetrician-gynecologists' knowledge and opinions about the United States Preventive Services Task Force (USPSTF) committee, the Women's Health Amendment, and the Affordable Care Act: national study after the release of the USPSTF 2009 Breast Cancer Screening Recommendation Statement.
    Anderson BL; Urban RR; Pearlman M; Schulkin J
    Prev Med; 2014 Feb; 59():79-82. PubMed ID: 24246966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice guidelines: how good are medicine's new recipes?
    Capron AM
    J Law Med Ethics; 1995; 23(1):47-8. PubMed ID: 7627301
    [No Abstract]   [Full Text] [Related]  

  • 40. Consensus development in biomedicine: the liver transplant controversy.
    Markle GE; Chubin DE
    Milbank Q; 1987; 65(1):1-24. PubMed ID: 3299031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.